Equity strategies

Carmignac Portfolio Human Xperience

ThematicArticle 9
Share Class

LU2601234839

A thematic Fund focused on customer and employee experience
  • Social thematic Fund : a thematic strategy that focuses both on customer and employee satisfaction.
  • Leveraging the power of social data : quantitative expertise and experience in using ‘alternative’ sources of data.
  • Material upside potential : research performed on all factors to backtest investability and alpha potential.
Key documents
Asset Allocation
Equities99.2 %
Other0.8 %
Data as of:  Oct 31, 2025.
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended Minimum Investment Horizon
5 years
Cumulative Performance since launch
+ 31.4 %
-
-
-
+ 4.5 %
From 14/04/2023
To 04/12/2025
Calendar Year Performance 2024
-
-
-
-
-
-
-
-
+ 10.6 %
+ 12.7 %
Net Asset Value
131.37 £
Asset Under Management
109 M €
Net Equity Exposure31/10/2025
99.2 %
SFDR - Fund Classification

Article

9
Data as of:  Dec 4, 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
The Sustainable Finance Disclosure Regulation (SFDR) 2019/2088 is a European regulation that requires asset managers to classify their funds as either 'Article 8' funds, which promote environmental and social characteristics, 'Article 9' funds, which make sustainable investments with measurable objectives, or 'Article 6' funds, which do not necessarily have a sustainability objective. For more information please refer to https://eur-lex.europa.eu/eli/reg/2019/2088/oj.

Carmignac Portfolio Human Xperience fund performance

Take a look at the Fund's performance supported by our Fund managers’ market commentary and strategy insight.

Our monthly comments

Data as of:  Nov 28, 2025.
Fund management team
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst

Market environment

  • Equity markets were broadly unchanged in November, but performance varied significantly beneath the surface.
  • Growth stocks, despite solid fundamentals, struggled to lead, while traditionally defensive areas like healthcare and consumer staples saw a clear rebound.
  • The end of the U.S. government shutdown did little to boost sentiment, as investors remained cautious amid mixed economic signals, questions around the growth outlook, and uncertainty on the direction of monetary policy.
  • Q3 earnings season ended on a strong note. In the U.S., 81% of S&P 500 companies beat expectations, with earnings up 13% year-on-year. Tech results were particularly strong, but the market didn’t react, suggesting that expectations are already high.
  • In Europe, financials and technology continued to deliver solid results, while consumer sectors, especially autos, were weaker. European equities slightly outperformed, supported by robust earnings growth prospects for 2026.
  • Elsewhere in Asia, markets softened as investors took profits after a strong year, with Korea and Taiwan retreating following a pullback in AI-related names.

Performance commentary

  • Over the month of November, the fund performed in line with its reference indicator and lagged slightly in absolute terms.
  • We saw an overall pick up in quality names performing over the month.
  • While our structural overweight to consumer staples had a slight negative impact, stock selection was strong with L’Oreal and Colgate Palmolive among our largest contributors in November. Both companies are supported by their strong pricing power , resilience in emerging markets and are currently trading at a discount to their intrinsic value.
  • In this reversal to more undervalued quality stocks, our fund suffered from its overweight to the tech sector with a noticeable reversal out of names like Nvidia, TSMC and Atlassian, in November.
  • In this environment we saw a continued pick up in Eli Lilly one of our few healthcare names as well as in consumer discretionary names like Marriott and Hilton.

Outlook strategy

  • In November, we continued building our positions in ASML and BBVA which we initiated at the end of October and initiated a position in Atlassian, a software company which was negatively affected on the basis of AI disruption.
  • We believe this AI disruption risk is overated for such a company with consistent growth.
  • We too some profits in Colgate Palmolive and Eli Lilly on the back of strong performance over the month.
  • We remain cautious in positioning our portfolio and continue to focus on higher quality companies.

Performance Overview

Data as of:  Dec 4, 2025.
​Past performance is not necessarily indicative of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor).
Morningstar Rating™ :  © Morningstar, Inc. All Rights Reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
​From 01/01/2013 the equity index reference indicators are calculated net dividends reinvested.
The return may increase or decrease as a result of currency fluctuations, for the shares which are not currency-hedged.
Source: Carmignac at 06/12/2025

Carmignac Portfolio Human Xperience Portfolio overview

Below is an overview of the composition of the portfolio.

Geographical Breakdown

Data as of:  Oct 31, 2025.
North America58.5 %
Europe26.6 %
Asia11.4 %
Asia-Pacific3.5 %
View details

Key figures

Below are the key figures for the Fund, which will give you a clearer idea of the Fund's management and equity positioning.

Exposure Data

Data as of:  Oct 31, 2025.
Equity Investment Weight99.2 %
Net Equity Exposure99.2 %
Number of Equity Issuers41
Active Share75.4 %

The strategy in a nutshell

Discover the Fund’s main features and benefits through the words of the Fund Manager.
Fund Management Team
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst
The social theme is one of the most disregarded areas within ESG. Yet we believe that companies providing positive experiences to both their customers and employees are better positioned to achieve superior returns over the long run.
[Management Team] [Author] Ejikeme Obe

Obe EJIKEME

Fund Manager, Analyst
View Fund's characteristics

Articles that may interest you

Strategies insightsOctober 23, 2025English

Carmignac Portfolio Human Xperience: Letter from the Fund Manager - Q3 2025

5 minute(s) read
Find out more
Strategies insightsOctober 15, 2025English

Carmignac Portfolio Human Xperience: Timely, tangible, transformative

3 minute(s) read
Find out more
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.